Drug Shortage Report for ONDANSETRON INJECTION, USP

Last updated on 2018-10-20 History
Report ID 13535
Drug Identification Number 02390019
Brand name ONDANSETRON INJECTION, USP
Common or Proper name ONDANSETRON INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ONDANSETRON
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 4ML 5VL, 2ML 5VL
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-09-17
Estimated end date 2018-10-30
Actual end date 2018-10-19
Shortage status Resolved
Updated date 2018-10-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v41 2018-10-20 English Compare
v40 2018-10-19 French Compare
v39 2018-10-19 English Compare
v38 2018-10-16 French Compare
v37 2018-10-16 English Compare
v36 2018-10-03 French Compare
v35 2018-10-03 English Compare
v34 2018-09-18 English Compare
v33 2018-09-17 French Compare
v32 2018-09-17 English Compare
v31 2018-06-01 English Compare
v30 2018-05-31 French Compare
v29 2018-05-31 English Compare
v28 2018-05-28 French Compare
v27 2018-05-28 English Compare
v26 2018-05-24 French Compare
v25 2018-05-24 English Compare
v24 2018-05-04 French Compare
v23 2018-05-04 English Compare
v22 2018-05-01 French Compare

Showing 1 to 20 of 41